News coverage about Kindred Healthcare (NYSE:KND) has trended somewhat positive recently, according to Accern. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Kindred Healthcare earned a media sentiment score of 0.23 on Accern’s scale. Accern also gave media stories about the health services provider an impact score of 45.4497793447426 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
These are some of the media stories that may have impacted Accern Sentiment’s analysis:
- Notable Watch List: New Senior Investment Group Inc., (NYSE: SNR), Kindred Healthcare, Inc., (NYSE: KND), YPF … – Stocks In The News (press release) (tradingnewsnow.com)
- Kindred Healthcare, Inc. (KND) Gives a Face-Lift on Volatility Measure and Performance – Stock News Stop (stockmarketstop.com)
- Kindred Healthcare, Inc. (KND) Try to Shakeup Active Momentum on New Compulsions – Stock News Stop (stockmarketstop.com)
- Kindred Healthcare, Inc. (KND) Receives Average Rating of “Hold” from Analysts (americanbankingnews.com)
Several equities research analysts recently commented on the stock. Zacks Investment Research downgraded shares of Kindred Healthcare from a “hold” rating to a “sell” rating in a research report on Wednesday, August 30th. Royal Bank of Canada reduced their price target on shares of Kindred Healthcare from $9.00 to $7.50 and set a “sector perform” rating for the company in a research report on Thursday, September 21st. Mizuho reiterated a “neutral” rating and issued a $7.50 target price (down previously from $8.00) on shares of Kindred Healthcare in a research report on Tuesday, October 10th. Deutsche Bank reiterated a “hold” rating and issued a $9.00 target price (down previously from $10.00) on shares of Kindred Healthcare in a research report on Monday, September 18th. Finally, Bank of America cut their target price on shares of Kindred Healthcare from $7.50 to $6.50 and set an “underperform” rating for the company in a research report on Thursday, September 21st. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $8.86.
Kindred Healthcare (NYSE:KND) last released its earnings results on Monday, November 6th. The health services provider reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.08. Kindred Healthcare had a negative net margin of 8.06% and a positive return on equity of 2.29%. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the firm earned $0.05 EPS. The company’s revenue was down 5.5% compared to the same quarter last year. equities analysts expect that Kindred Healthcare will post 0.32 earnings per share for the current year.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
Receive News & Ratings for Kindred Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.